Long Term Debt Summary of PharmaEngine, Inc.

PharmaEngine, Inc.'s latest annual long term debt in 2023 was 7.14 Million TWD , down -51.77% from previous year.
PharmaEngine, Inc.'s latest quarterly long term debt in 2024 Q2 was 3.26 Million TWD , down 0.0% from previous quarter.
PharmaEngine, Inc. reported annual long term debt of 14.8 Million TWD in 2022, down 0.0% from previous year.
PharmaEngine, Inc. reported annual long term debt of - TWD in 2021, down -100.0% from previous year.
PharmaEngine, Inc. reported quarterly long term debt of 5.2 Million TWD for 2024 Q1, down 0.0% from previous quarter.
PharmaEngine, Inc. reported quarterly long term debt of 12.9 Million TWD for 2023 Q1, down -12.86% from previous quarter.

Annual Long Term Debt Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Long Term Debt of PharmaEngine, Inc. (2023 - 2009)

Year	Long Term Debt	Long Term Debt Growth
2023	7.14 Million TWD	-51.77%
2022	14.8 Million TWD	0.0%
2021	- TWD	-100.0%
2020	11.31 Million TWD	-48.47%
2019	21.95 Million TWD	0.0%
2018	- TWD	0.0%
2017	- TWD	0.0%
2016	- TWD	0.0%
2015	- TWD	0.0%
2014	- TWD	0.0%
2013	- TWD	0.0%
2012	- TWD	0.0%
2011	- TWD	0.0%
2010	- TWD	0.0%
2009	- TWD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	3.26 Million TWD	0.0%
2024 Q1	5.2 Million TWD	0.0%
2023 Q1	12.9 Million TWD	-12.86%
2023 Q3	9.07 Million TWD	-17.47%
2023 Q4	7.14 Million TWD	-21.26%
2023 FY	7.14 Million TWD	-51.77%
2023 Q2	10.99 Million TWD	-14.82%
2022 Q1	- TWD	0.0%
2022 Q3	- TWD	0.0%
2022 Q4	14.8 Million TWD	0.0%
2022 FY	14.8 Million TWD	0.0%
2022 Q2	- TWD	0.0%
2021 Q2	6.23 Million TWD	-28.42%
2021 Q3	1.28 Million TWD	-79.44%
2021 Q4	- TWD	-100.0%
2021 Q1	8.71 Million TWD	-22.99%
2021 FY	- TWD	-100.0%
2020 Q4	11.31 Million TWD	-17.32%
2020 Q3	13.68 Million TWD	-16.26%
2020 FY	11.31 Million TWD	-48.47%
2020 Q1	19.08 Million TWD	-13.07%
2020 Q2	16.33 Million TWD	-14.39%
2019 Q3	6.66 Million TWD	-11.87%
2019 Q4	21.95 Million TWD	229.29%
2019 FY	21.95 Million TWD	0.0%
2019 Q1	8.1 Million TWD	0.0%
2019 Q2	7.56 Million TWD	-6.66%
2018 Q1	- TWD	0.0%
2018 Q4	- TWD	0.0%
2018 Q3	- TWD	0.0%
2018 Q2	- TWD	0.0%
2018 FY	- TWD	0.0%
2017 Q1	- TWD	0.0%
2017 Q4	- TWD	0.0%
2017 Q3	- TWD	0.0%
2017 Q2	- TWD	0.0%
2017 FY	- TWD	0.0%
2016 Q3	- TWD	0.0%
2016 FY	- TWD	0.0%
2016 Q2	- TWD	0.0%
2016 Q1	- TWD	0.0%
2016 Q4	- TWD	0.0%
2015 Q3	- TWD	0.0%
2015 Q4	- TWD	0.0%
2015 Q2	- TWD	0.0%
2015 Q1	- TWD	0.0%
2015 FY	- TWD	0.0%
2014 Q3	- TWD	0.0%
2014 Q2	- TWD	0.0%
2014 Q1	- TWD	0.0%
2014 FY	- TWD	0.0%
2014 Q4	- TWD	0.0%
2013 Q2	- TWD	0.0%
2013 Q4	- TWD	0.0%
2013 Q3	- TWD	0.0%
2013 Q1	- TWD	0.0%
2013 FY	- TWD	0.0%
2012 FY	- TWD	0.0%
2012 Q2	- TWD	0.0%
2012 Q3	- TWD	0.0%
2012 Q1	- TWD	0.0%
2012 Q4	- TWD	0.0%
2011 Q4	- TWD	0.0%
2011 FY	- TWD	0.0%
2010 FY	- TWD	0.0%
2009 FY	- TWD	0.0%

Peer Long Term Debt Comparison of PharmaEngine, Inc.

Name	Long Term Debt	Long Term Debt Difference
SYN-TECH Chem. & Pharm. Co., Ltd.	60.65 Million TWD	88.223%
Level Biotechnology Inc.	9.88 Million TWD	27.739%
Sagittarius Life Science Corp	6.25 Million TWD	-14.215%
NeoCore Technology Co., Ltd.	33.65 Million TWD	78.774%
TaiMed Biologics Inc.	521.7 Million TWD	98.631%
GlycoNex Incorporation	- TWD	-Infinity%
VBI	- TWD	-Infinity%
GeneReach Biotechnology Corp.	97.74 Million TWD	92.692%
Taiwan Advance Bio-Pharmaceutical Inc.	86.89 Million TWD	91.779%
Visgeneer Inc.	114.17 Million TWD	93.744%
Mycenax Biotech Inc.	569.78 Million TWD	98.746%
Sunmax Biotechnology Co., Ltd.	144.77 Million TWD	95.066%
G&E Herbal Biotechnology Co., Ltd.	1.29 Million TWD	-452.009%
Medigen Vaccine Biologics Corporation	254.35 Million TWD	97.192%
TaiwanJ Pharmaceuticals Co., Ltd.	472 Thousand TWD	-1413.347%
Enimmune corporation	1.75 Million TWD	-306.083%
TaiRx, Inc.	8.96 Million TWD	20.359%
CHO Pharma, Inc.	- TWD	-Infinity%
EirGenix Inc.	436.54 Million TWD	98.364%
BioLASCO Taiwan Co., Ltd.	51.43 Million TWD	86.112%
Sunny Pharmtech Inc.	376.29 Million TWD	98.102%
Lin BioScience, Inc.	29.02 Million TWD	75.391%
BioGend Therapeutics Co., Ltd.	9.44 Million TWD	24.341%
Feng Chi Biotech Corp.	8.14 Million TWD	12.345%
Bio Preventive Medicine Corp.	106.2 Million TWD	93.274%
Lukas Biomedical Inc.	69.9 Million TWD	89.782%
RBC Bioscience Corporation	412.59 Million TWD	98.269%
BiOptic Inc.	85.79 Million TWD	91.674%
BRIM Biotechnology, Inc.	108 Thousand TWD	-6513.889%
Shine-On BioMedical Co.,Ltd.	- TWD	-Infinity%
Great Novel Therapeutics Biotech & Medicals	10.88 Million TWD	34.353%
Syngen Biotech Co.,Ltd.	386.07 Million TWD	98.15%
Anti-Microbial Savior BioteQ Co., Ltd	- TWD	-Infinity%
SynCore Biotechnology Co.,Ltd	- TWD	-Infinity%
Genomics BioSci & Tech. Co.,Ltd.	222.24 Million TWD	96.786%
Neith Corporation	714 Thousand TWD	-900.42%
Advagene Biopharma Co., Ltd.	- TWD	-Infinity%
NaviFUS Corp.	25.83 Million TWD	72.354%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	366 Million TWD	98.048%
Sinew Pharma Inc.	- TWD	-Infinity%
Andros Pharmaceuticals Co.,Ltd	22.02 Million TWD	67.567%
Greenyn Biotechnology Co., Ltd	55.91 Million TWD	87.226%
Lumosa Therapeutics Co., Ltd.	8.11 Million TWD	12.0%
AP Biosciences Inc	70.42 Million TWD	89.858%
Medigen Biotechnology Corp.	449.09 Million TWD	98.409%
3D Global Biotech Inc.	4.08 Million TWD	-74.988%
Pharmosa Biopharm Inc.	118.41 Million TWD	93.968%
Intech Biopharm Corporation	970.4 Million TWD	99.264%
Oneness Biotech Co., Ltd.	397.95 Million TWD	98.205%
Eusol Biotech Co.,Ltd.	1.6 Million TWD	-344.77%
TWi Biotechnology, Inc.	5.6 Million TWD	-27.485%
Ever Supreme Bio Technology Co., Ltd	503 Thousand TWD	-1320.08%
TCI GENE Inc.	- TWD	-Infinity%
MegaPro Biomedical Co., Ltd	5.62 Million TWD	-26.919%
Senhwa Biosciences, Inc.	3.28 Million TWD	-117.311%
Taiwan Bio Therapeutics Co., Ltd	250.51 Million TWD	97.149%
NatureWise Biotech & Medicals Corporation	3.26 Million TWD	-118.775%
Savior Lifetec Corporation	257.03 Million TWD	97.221%
TaiGen Biopharmaceuticals Holdings Limited	58.71 Million TWD	87.833%
OBI Pharma, Inc.	439.88 Million TWD	98.376%
Meribank Biotech Co., Ltd	14.81 Million TWD	51.772%
Acepodia, Inc.	233.45 Million TWD	96.94%
Caliway Biopharmaceuticals Co., Ltd.	11.87 Million TWD	39.843%

Global Stocks Search

PharmaEngine, Inc. (4162.TWO)

Long Term Debt Summary of PharmaEngine, Inc.

Annual Long Term Debt Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Long Term Debt of PharmaEngine, Inc. (2023 - 2009)

Peer Long Term Debt Comparison of PharmaEngine, Inc.